Novavax Claims Covid-19 Vaccine 89 percent Effective In United Kingdom trial, less in South Africa, Shares Jump

An other new Covid-19 vaccine from Novavax was found to be 89 percent effective in a clinical trial conducted in the United Kingdom and appears to offer protection against some variants of the coronavirus, the American based pharma company biotech 

Read More 

Advertisement: Jewelry, Medical Supplies and Equipment
Coronavirus Updates, Luxury Eyewear
Tools and Fashion Accessories, Cell Phone and Accessories
Outdoor and Sports Fitness, Medical Supplies and Equipment